REQUEST A DEMO
Total
USD $0.00
Search more companies

Max-Pharma Sp. z o.o. (Poland)

Main Activities: Department Stores
Full name: Max-Pharma Sp. z o.o. Profile Updated: November 09, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Max-Pharma Sp. z o.o. is a company in Poland, with a head office in Warsaw. It operates in the Department Stores industry. It was incorporated on March 04, 2016. The total number of employees is currently 1 (2016). From the latest financial highlights, Max-Pharma Sp. z o.o. reported a net sales revenue increase of 24.63% in 2022. There was a total growth of 4.52% in Max-Pharma Sp. z o.o.’s total assets over the same period. Max-Pharma Sp. z o.o.’s net profit margin increased by 2.37% in 2022.

Headquarters
Ul. Zwirki I Wigury 16A/Biuro 315
Warsaw; Mazowieckie; Postal Code: 02-092

Contact Details: Purchase the Max-Pharma Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Max-Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Max-Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Max-Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Max-Pharma Sp. z o.o. report to view the information.
Incorporation Date:
March 04, 2016
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Max-Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
24.63%
Total operating revenue
22.72%
Operating profit (EBIT)
92.58%
EBITDA
N/A
Net Profit (Loss) for the Period
34.37%
Total assets
4.52%
Total equity
-8.98%
Operating Profit Margin (ROS)
1.81%
Net Profit Margin
2.37%
Return on Equity (ROE)
-5.45%
Quick Ratio
0%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?